Doctor Francesca Stillitano
Icahn School of Medicine at Mount Sinai, New York (United States of America)
Gene therapy to avoid development of cardiomyopathy
Event: ESC Preventive Cardiology 2023
Topic: Biomarkers
Session: How genes and the environment interact to shape individual CV risk
Genetic correction of phospholamban mutations in vitro and in vivo human-based models
Event: Frontiers in CardioVascular Biomedicine 2022
Topic: Genetics, Epigenetics, ncRNA
Session: Gene editing for the heart: progress and hurdles
In vitro and in vivo genome engineering of Dilated Cardiomyopathy caused by phospholamban R14 deletion.
Event: Frontiers in CardioVascular Biology 2016
Topic: Gene therapy
Session: Moderated Poster session - Genetic, Epigenetic & Integrative
Modeling susceptibility to drug-induced long qt syndrome with a panel of subject-specific induced pluripotent stem cells
Event: Frontiers in CardioVascular Biology 2016
Topic: Cell growth, differentiation and stem cells - Heart
Session: Control of rhythm and rate
ESC 365 is supported by
